Population requiring preventive chemotherapy for schistosomiasis in Zimbabwe
Zimbabwe: Population requiring preventive chemotherapy for schistosomiasis was 2.71 million in 2024. ▼ Falling
Population requiring preventive chemotherapy for schistosomiasis in Zimbabwe, 2010–2024
Source: Our World in Data.
Analysis
The most recent figure for population requiring preventive chemotherapy for schistosomiasis in Zimbabwe is 2.71 million, measured in 2024.
The figure is up 127.7% on the previous year and down 16.7% over ten years.
Over the whole period, population requiring preventive chemotherapy for schistosomiasis in Zimbabwe peaked at 4.38 million in 2017 and was at its lowest, 1.19 million, in 2023.
Zimbabwe ranks 27th of 52 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 15 years of available data.
Population requiring preventive chemotherapy for schistosomiasis in Zimbabwe, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 2.97 million | — |
| 2011 | 3.00 million | +1.1% |
| 2012 | 3.06 million | +2.0% |
| 2013 | 3.15 million | +3.1% |
| 2014 | 3.26 million | +3.2% |
| 2015 | 3.68 million | +12.9% |
| 2016 | 4.04 million | +10.0% |
| 2017 | 4.38 million | +8.4% |
| 2018 | 3.83 million | -12.7% |
| 2019 | 3.83 million | +0.0% |
| 2020 | 3.41 million | -10.9% |
| 2021 | 3.46 million | +1.5% |
| 2022 | 3.33 million | -4.0% |
| 2023 | 1.19 million | -64.2% |
| 2024 | 2.71 million | +127.6% |
Zimbabwe compared with similar countries
- Zimbabwe's 2.71 million is below the median for lower middle income countries, which is 3.09 million, 88% of the median. (22 countries reporting)
- Zimbabwe's 2.71 million is below the median for Sub-Saharan Africa, which is 3.38 million, 80% of the median. (43 countries reporting)
Biggest year-on-year movements
Years where Population requiring preventive chemotherapy for schistosomiasis in Zimbabwe changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2024 | +127.6% | 1.19 million | 2.71 million |
| 2023 | -64.2% | 3.33 million | 1.19 million |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3.52 million | 2.97 million | 4.38 million | 10 |
| 2020s | 2.82 million | 1.19 million | 3.46 million | 5 |
Countries ranked near Zimbabwe
More population data for Zimbabwe
- Population regions with projections, annual growth rate 0.1887 % change on previous year (2100)
- Urban and rural population 2050, annual growth rate -0.0209 % change on previous year (2050)
- Population long run with projections, annual growth rate 0.1887 % change on previous year (2100)
- Un population 2024 vs 2022, annual growth rate 0.0944 % change on previous year (2100)
- Africa's Development Dynamics (AfDD) Table 05 - Demographic estimates 26,439 Persons (2050)
- Africa's Development Dynamics (AfDD) Table 03 - Annual population 1.94 Percent per annum (2030)
- Projected population under age 5, annual growth rate -0.5219 % change on previous year (2100)
- Population growth rate 0.188 (2100)
- Population density 96.07 (2100)
- Projected population under age 5 2.49 million (2100)
Frequently asked questions
- What is population requiring preventive chemotherapy for schistosomiasis in Zimbabwe?
- Population requiring preventive chemotherapy for schistosomiasis in Zimbabwe was 2.71 million in 2024, according to Our World in Data.
- What is the highest population requiring preventive chemotherapy for schistosomiasis recorded in Zimbabwe?
- The highest recorded value was 4.38 million in 2017.
- What is the lowest population requiring preventive chemotherapy for schistosomiasis recorded in Zimbabwe?
- The lowest recorded value was 1.19 million in 2023.
- How does Zimbabwe rank for population requiring preventive chemotherapy for schistosomiasis?
- Zimbabwe ranks 27th out of 52 countries with data for 2024.
- Is population requiring preventive chemotherapy for schistosomiasis rising or falling in Zimbabwe?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Zimbabwe data come from?
- The figures come from Our World in Data, published as part of Population requiring preventive chemotherapy for schistosomiasis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).